FDA approves Zepbound, a new obesity drug that will take on Wegovy
Drugmaker Eli Lilly & Co. received Food and Drug Administration approval for an obesity drug called Zepbound that will be a rival to Novo Nordisk's Wegovy.Darron Cummings/AP A…
More from Minnesota Business
Star Tribune Business
Trump allies stand to gain from Minnesota ore company with Iowa steel dreams
Minnesota Business
•
25m ago
Star Tribune Business
Summit Brewing could avoid foreclosure with new lender
Minnesota Business
•
1d ago
Star Tribune Business
Watch the replays of the North Star Summit sessions
Minnesota Business
•
1d ago
Star Tribune Business
Social Security recipients to get 3.6% cost of living boost, an average of $75 per month
Minnesota Business
•
2d ago
MPR Business
Minnesota company leads manufacturing of quartz countertops that California poised to ban
Minnesota Business
•
2d ago